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Robert Truitt TributeIt is with great pleasure that we are able to pay trib-
ute to Robert Truitt, PhD, for his many contributions
to the field of hematopoietic stem cell transplantation.
Bob will be stepping down at the end of this year from
a career in experimental allogeneic bonemarrow trans-
plantation that spans more than three decades. He is
recognized as one of the pioneers in the use of experi-
mental mouse models to separate GVL from GVHD,
and his work has provided many important contribu-
tions towards understanding the cellular nature of
the GVL effect.
Bob began his career in animal models of hemato-
poietic stem cell transplantation in 1972, as a postdoc-
toral fellow in Morris Pollards’s laboratory at the
University of Notre Dame’s Lobund laboratory.
His early work focused on the generation of alloge-
neic bone marrow chimerism in germfree mice to
prevent development of spontaneous tumors. In
1974, Bob was recruited to Milwaukee by Mortimer
Bortin then to the Mount Sinai Medical Center,where he studied the impact of gut decontamination
on the antileukemic effect of GVHD in MHC-mis-
matched bone marrow chimeras. This work set the
stage for his future focus on attempts to separate
GVL from GVHD. Using the aggressive AKR leuke-
mia model, Bob published a series of papers in the
early 1980s showing that alloimmunization of
MHC-matched donor mice with third party alloanti-
gens induced a population of T cells that could in
some cases mediate GVL without exacerbating
GVHD. These data suggested that GVL could in-
deed be separated from GVHD. To further support
this concept, Bob’s laboratory used split-well limiting
dilution analysis assays to show that although many of
the T cell clones from alloimmunized donors or
transplant recipients reacted to both leukemic and
non-leukemic cells of host origin, some clones ap-
peared to be truly leukemia specific. During this ex-
citing time in bone marrow transplantation, Bob
and Mortimer Bortin moved their laboratories nearby
to the Medical College of Wisconsin. His laboratory
continued to investigate the GVL effect, and he and
his colleagues went on to make several other impor-
tant findings including confirming the presence of
‘‘suppressor’’ T cells in bone marrow chimeras.
This set the stage for studies of tolerance mechanisms
in mixed chimeras involving the role of regulatory T
cells in controlling alloresponses and identification of
a series of factors that influence the balance between
GVHD, GVL, and tolerance. In addition, he and his
colleagues developed the first mouse model to inves-
tigate the GVL effect of post-transplant donor lym-
phocyte infusions that simulated the outcome seen
in patients. All of this work resulted in more than
100 publications that contributed to our knowledge
in this field.
Bone marrow transplantation clearly has benefited
from Bob’s contributions, in the experimental models
he developed, their applications into the clinic, and the
legacy of trainees that have themselves become leaders
in preclinical and clinical transplantation studies.
Many former students, postdoctoral fellows, and ju-
nior faculty will forever be indebted to the superb
mentorship and training that Bob provided during
his tenure.
Bob’s commitment and dedication to the field of
hematopoietic stem cell transplantation is evidenced
by his service to ASBMT over the years. Bob served
on the society’s Tumor Immunology Scientific Sub-
committee, Membership Committee, and Distance143
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rectors from 2004-2007, and has been a member of the
BBMT Editorial Board since 1995 (Associate Editor
since 2001). In recognition of his contributions to
the field of transplantation, Bob was bestowed the
honor of giving the first annual Mortimer Bortin Lec-
ture at the ASMBT annual meeting in 2004. During
his talk, Bob provided a wonderful historical perspec-
tive on GVL and GVHD, and he had the privilege to
highlight his former mentor’s many contributions to
the field of hematopoietic stem cell transplantation
(BBMT, 10:505).The transplant community extends their best
wishes to Bob as he takes on new and exciting chal-
lenges that life has to offer.
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